Literature DB >> 25444276

Balancing the innate immune system in tumor development.

Catharina Hagerling1, Amy-Jo Casbon1, Zena Werb2.   

Abstract

Cells of the innate immune system have a dual role in cancer development in both tumor initiation and progression. Innate immune cells can, on the one hand, aid malignant transformation and tumor outgrowth and, on the other hand, prevent tumor progression. The innate immune system has the ability to tune the inflammatory response and is a key player in cancer-related inflammation, which can precede the development of malignancy or be induced by oncogenic changes promoting a protumor inflammatory milieu. In this review, we discuss the emerging cellular and molecular mechanisms of the innate immune system and inflammation in tumor initiation and progression, and point to the outstanding questions that remain.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer development; inflammation; innate immune cells

Mesh:

Year:  2014        PMID: 25444276      PMCID: PMC4380818          DOI: 10.1016/j.tcb.2014.11.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  100 in total

Review 1.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

2.  CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα.

Authors:  Guangwen Ren; Xin Zhao; Ying Wang; Xin Zhang; Xiaodong Chen; Chunliang Xu; Zeng-rong Yuan; Arthur I Roberts; Liying Zhang; Betty Zheng; Ting Wen; Yanyan Han; Arnold B Rabson; Jay A Tischfield; Changshun Shao; Yufang Shi
Journal:  Cell Stem Cell       Date:  2012-11-15       Impact factor: 24.633

3.  TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Authors:  Annamaria Biroccio; Julien Cherfils-Vicini; Adeline Augereau; Sébastien Pinte; Serge Bauwens; Jing Ye; Thomas Simonet; Béatrice Horard; Karine Jamet; Ludovic Cervera; Aaron Mendez-Bermudez; Delphine Poncet; Renée Grataroli; Claire T'kint de Rodenbeeke; Erica Salvati; Angela Rizzo; Pasquale Zizza; Michelle Ricoul; Céline Cognet; Thomas Kuilman; Helene Duret; Florian Lépinasse; Jacqueline Marvel; Els Verhoeyen; François-Loïc Cosset; Daniel Peeper; Mark J Smyth; Arturo Londoño-Vallejo; Laure Sabatier; Vincent Picco; Gilles Pages; Jean-Yves Scoazec; Antonella Stoppacciaro; Carlo Leonetti; Eric Vivier; Eric Gilson
Journal:  Nat Cell Biol       Date:  2013-06-23       Impact factor: 28.824

Review 4.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

Review 5.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue.

Authors:  Gustaf Christoffersson; Evelina Vågesjö; Jennifer Vandooren; Majken Lidén; Sara Massena; Rachel B Reinert; Marcela Brissova; Alvin C Powers; Ghislain Opdenakker; Mia Phillipson
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

9.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

10.  Macrophage colony-stimulating factor augments Tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer.

Authors:  Mary A Forget; Jeffrey L Voorhees; Sara L Cole; Duaa Dakhlallah; Ivory L Patterson; Amy C Gross; Leni Moldovan; Xiaokui Mo; Randall Evans; Clay B Marsh; Tim D Eubank
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more
  39 in total

1.  Delineating CSF-1-dependent regulation of myeloid cell diversity in tumors.

Authors:  Amy-Jo Casbon; Marja Lohela; Zena Werb
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

2.  Heparanase and cancer progression: New directions, new promises.

Authors:  Gil Arvatz; Marina Weissmann; Neta Ilan; Israel Vlodavsky
Journal:  Hum Vaccin Immunother       Date:  2016-04-07       Impact factor: 3.452

3.  G3BP1 and G3BP2 regulate translation of interferon-stimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7.

Authors:  Umber Alam; Derek Kennedy
Journal:  Mol Cell Biochem       Date:  2019-06-06       Impact factor: 3.396

4.  Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway.

Authors:  Junru Li; Huifang Li; Yu Yu; Yan Liu; Yunzhi Liu; Qiang Ma; Liyun Zhang; Xiao Lu; Xiang-Yang Wang; Zhengliang Chen; Daming Zuo; Jia Zhou
Journal:  Oncoimmunology       Date:  2018-10-10       Impact factor: 8.110

Review 5.  A primer on tumour immunology and prostate cancer immunotherapy.

Authors:  Runhan Ren; Madhuri Koti; Thomas Hamilton; Charles H Graham; Jasmir G Nayak; Jas Singh; Darrel E Drachenberg; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

Review 6.  Endoplasmic reticulum proteostasis: a key checkpoint in cancer.

Authors:  Scott A Oakes
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-16       Impact factor: 4.249

7.  STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.

Authors:  Laura M Jones; Miranda L Broz; Jill J Ranger; John Ozcelik; Ryuhjin Ahn; Dongmei Zuo; Josie Ursini-Siegel; Michael T Hallett; Matthew Krummel; William J Muller
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

Review 8.  Immunomethylomics: A Novel Cancer Risk Prediction Tool.

Authors:  Karl T Kelsey; John K Wiencke
Journal:  Ann Am Thorac Soc       Date:  2018-04

9.  Effects of Chlorella vulgaris on tumor growth in mammary tumor-bearing Balb/c mice: discussing association of an immune-suppressed protumor microenvironment with serum IFNγ and IgG decrease and spleen IgG potentiation.

Authors:  Ahad Khalilnezhad; Elham Mahmoudian; Nariman Mosaffa; Ali Anissian; Mohsen Rashidi; Davar Amani
Journal:  Eur J Nutr       Date:  2017-02-22       Impact factor: 5.614

Review 10.  The Role of Stroma in Tumor Development.

Authors:  Zena Werb; Pengfei Lu
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.